ASTEX PHARMACEUTICALS, INC Accumulated Other Comprehensive Income
ASTEX PHARMACEUTICALS, INC had Accumulated Other Comprehensive Income of -$7.67 million as of 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2013-08-09
- 2013-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$7.67M.
- 2013-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$7.87M.
- 2012-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.78M.
- 2011-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$6.68M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2013-06-30 | -$7.67M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$7.87M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$1.78M 10-Q · filed 2013-08-09 |
| 2011-12-31 | -$6.68M 10-K · filed 2013-03-18 |